Functional portal flow competition after auxiliary partial orthotopic living donor liver transplantation in noncirrhotic metabolic liver disease

被引:33
|
作者
Kasahara, M [1 ]
Takada, Y [1 ]
Kozaki, K [1 ]
Uryuhara, K [1 ]
Ogura, Y [1 ]
Ogawa, K [1 ]
Fujimoto, Y [1 ]
Tanaka, K [1 ]
机构
[1] Kyoto Univ Hosp, Dept Transplant Surg, Sakyo Ku, Kyoto 6068507, Japan
关键词
auxiliary liver transplantation; living donor liver transplantation; noncirrhotic metabolic liver disease; ornithine transcarbamylase deficiency;
D O I
10.1016/j.jpedsurg.2004.03.079
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Auxilliary partial orthotopic liver transplantation (APOLT) was introduced initially as a tentative or permanent support for patients with potentially reversible fulminant hepatic failure and has extended its indication to congenital metabolic disorder of the liver that has otherwise normal functional integrity. Postoperative management of APOLT is complicated because of functional portal flow competition between the native and graft liver. The native portal vein diversion to the graft is sometimes indicated to prevent functional competition; however, it is still an open question whether this technique can be theoretically indicated for APOLT patients. The authors report a on patient with ornithine transcarbamylase deficiency who received APOLT from a living donor without native portal vein diversion. Because of functional portal vein competition between the native and graft liver, the patient had to have portal vein diversion, portal vein embolization, and finally native hepatectomy to induce the graft regeneration after APOLT. After the experience of the current case, primary portal vein diversion for APOLT with noncirrhotic metabolic liver disease patients to prevent functional portal flow competition is recommended. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:1138 / 1141
页数:4
相关论文
共 50 条
  • [21] Severe late acute allograft rejection in a child after living-related auxiliary partial orthotopic liver transplantation for ornithine transcarbamylase deficiency
    Komatsu, H
    Inui, A
    Fujisawa, T
    Sogo, T
    Miyagawa, Y
    Inui, M
    Uemoto, S
    Inomata, Y
    Tanaka, K
    CLINICAL TRANSPLANTATION, 1999, 13 (04) : 300 - 304
  • [22] The impact of metabolic syndrome and prevalent liver disease on living donor liver transplantation: a pressing need to expand the pool
    Al-hamoudi, Waleed
    Abaalkhail, Faisal
    Bendahmash, Abdurahman
    Allam, Naglaa
    Hegab, Bassem
    Elsheikh, Yasser
    Al-bahili, Hamad
    Almasri, Nasser
    Al-sofayan, Mohammed
    Alabbad, Saleh
    Al-Sebayel, Mohammed
    Broering, Dieter
    Elsiesy, Hussien
    HEPATOLOGY INTERNATIONAL, 2016, 10 (02) : 347 - 354
  • [23] The impact of metabolic syndrome and prevalent liver disease on living donor liver transplantation: a pressing need to expand the pool
    Waleed Al-hamoudi
    Faisal Abaalkhail
    Abdurahman Bendahmash
    Naglaa Allam
    Bassem Hegab
    Yasser Elsheikh
    Hamad Al-bahili
    Nasser Almasri
    Mohammed Al-sofayan
    Saleh Alabbad
    Mohammed Al-Sebayel
    Dieter Broering
    Hussien Elsiesy
    Hepatology International, 2016, 10 : 347 - 354
  • [24] Intra-operative management of low portal vein flow in pediatric living donor liver transplantation
    Lin, Ting-Lung
    Chiang, Li-Wei
    Chen, Chao-Long
    Wang, Shih-Hor
    Lin, Chih-Che
    Liu, Yueh-Wei
    Yong, Chee-Chien
    Lin, Tsan-Shiun
    Li, Wei-Feng
    Jawan, Bruno
    Cheng, Yu-Fan
    Chen, Tai-Yi
    Concejero, Allan M.
    Wang, Chih-Chi
    TRANSPLANT INTERNATIONAL, 2012, 25 (05) : 586 - 591
  • [25] Antithrombin III treatment for portal vein thrombosis after living donor liver transplantation: a case report
    Yuta Hirata
    Yukihiro Sanada
    Takahiko Omameuda
    Takumi Katano
    Go Miyahara
    Naoya Yamada
    Noriki Okada
    Yasuharu Onishi
    Yasunaru Sakuma
    Naohiro Sata
    Surgical Case Reports, 6
  • [26] EVALUATION, SELECTION AND PREPARATION OF LIVING DONOR FOR PARTIAL LIVER TRANSPLANTATION IN CHILDREN
    Gautier, S. V.
    Monakhov, A. R.
    VESTNIK TRANSPLANTOLOGII I ISKUSSTVENNYH ORGANOV, 2015, 17 (01): : 134 - 146
  • [27] Antithrombin III treatment for portal vein thrombosis after living donor liver transplantation: a case report
    Hirata, Yuta
    Sanada, Yukihiro
    Omameuda, Takahiko
    Katano, Takumi
    Miyahara, Go
    Yamada, Naoya
    Okada, Noriki
    Onishi, Yasuharu
    Sakuma, Yasunaru
    Sata, Naohiro
    SURGICAL CASE REPORTS, 2020, 6 (01)
  • [28] Endovascular management of portal steal syndrome due to portosystemic shunts after living donor liver transplantation
    Jajodia, Surabhi
    Khandelwal, Anubhav H.
    Khandelwal, Rohit
    Kapoor, Abhay K.
    Baijal, Sanjay S.
    JGH OPEN, 2021, 5 (05): : 599 - 606
  • [29] Revolution and refinement of surgical techniques for living donor partial liver transplantation
    Dulundu, E
    Sugawara, Y
    Makuuchi, M
    YONSEI MEDICAL JOURNAL, 2004, 45 (06) : 1076 - 1088
  • [30] Living donor liver transplantation for idiopathic portal hypertension with focal nodular hyperplasia
    Tanji, Yoshiaki
    Furukawa, Kenei
    Igarashi, Yosuke
    Yanagaki, Mitsuru
    Haruki, Koichiro
    Shirai, Yoshihiro
    Taniai, Tomohiko
    Gocho, Takeshi
    Okui, Norimitsu
    Ikegami, Toru
    SURGICAL CASE REPORTS, 2022, 8 (01)